Quality Control
Supported
by Science
AMSlab is a group of biotech companies specialising in analytical solutions for various sectors, such as veterinary services, pharmaceuticals, food and healthcare.
AMSlab in figures
- +30 R&D projects
- +45 countries
- +15 years of experience
- +5.000 m² of facilities
- +1.200 clients
News

How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients
In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure, set off […]
Read more
AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector
AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the chemical, pharmaceutical, […]
Read more
New update for ICH Q2 (R2) Analytical process validation guidance
As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2 (R2) Guideline […]
Read more